HomeCLYYF • OTCMKTS
add
Celyad Oncology SA
Previous close
$0.65
Year range
$0.25 - $0.68
Market cap
19.19M EUR
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 86.00K | 196.55% |
Operating expense | 1.48M | -37.95% |
Net income | -1.39M | 40.95% |
Net profit margin | -1.62K | 80.09% |
Earnings per share | — | — |
EBITDA | -1.35M | 41.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.20M | -40.03% |
Total assets | 9.93M | -39.02% |
Total liabilities | 9.42M | -5.62% |
Total equity | 511.00K | — |
Shares outstanding | 41.43M | — |
Price to book | 65.00 | — |
Return on assets | -35.08% | — |
Return on capital | -245.94% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.39M | 40.95% |
Cash from operations | -1.42M | 58.54% |
Cash from investing | 7.50K | 102.69% |
Cash from financing | 404.00K | -91.46% |
Net change in cash | -1.01M | -200.05% |
Free cash flow | -704.25K | 47.64% |
About
Founded
2004
Headquarters
Website
Employees
18
